Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > Healthcare company Sanofi announces share buyback of up to 2 billion euros

Finance

Healthcare company Sanofi announces share buyback of up to 2 billion euros

Published by Global Banking and Finance Review

Posted on February 7, 2025

Featured image for article about Finance

PARIS (Reuters) - French healthcare company Sanofi announced on Friday a share buyback plan worth up to 2 billion euros ($2.1 billion), which would be done between now and the end of December.

($1 = 0.9640 euros)

(Reporting by Sudip Kar-Gupta; Editing by Jamie Freed)

Explainer-What are the legal risks of EU's 'reparations loan' for Ukraine?

Ice-cream spin-off turns up heat on Unilever to deliver on growth, margins

Google faces $129 million French asset freeze after Russian ruling, documents show

Hundreds of storks found dead near Madrid amid wider bird flu surge

EIB to boost lending for EU defence projects in 2026

Austrian former tycoon Benko will appeal fraud conviction, lawyer says

Israel gives legal status to 19 West Bank settlements, media reports

Volvo Cars urges EU to resist pressure to scrap fossil-fuel autos ban

Russia attacks two Ukrainian ports, damaging three Turkish-owned vessels

UK's Card Factory warns on profit as weak sales dim holiday outlook

Fraport expects significant decline in 2026 net earnings, first dividend since 2019

EU drugs regulator backs higher dose of Novo's Wegovy

Healthcare company Sanofi announces share buyback of up to 2 billion euros

Healthcare company Sanofi announces share buyback of up to 2 billion euros

More from Finance

SEAT says EU's rethink on 2035 combustion-engine ban could help EV transition

EU open to accommodate Belgian concerns on guarantees in Russian asset plan

Less New York, more Nashville: Europeans head to smaller US cities

EU aluminium and cement imports to face higher emissions costs, draft shows

Universal submits remedy to EU's objections over Downtown deal

Swiss to reduce F-35 fighter jet order from US as costs rise

Euroclear can offset its assets seized by Russia with Russia's assets -EU

Still no deal on European fighter jets after ministerial talks, sources say

Dutch report calls for $176 billion tech spend, jobless benefit cuts

China's Changan Automobile adds Italy and Spain to its European markets

Hensoldt to supply Rheinmetall's air defence division with radars

Analysis-Oracle's stumble hits AI trade, but many remain bullish

More from Finance

SEAT says EU's rethink on 2035 combustion-engine ban could help EV transition

EU open to accommodate Belgian concerns on guarantees in Russian asset plan

Less New York, more Nashville: Europeans head to smaller US cities

EU aluminium and cement imports to face higher emissions costs, draft shows

Universal submits remedy to EU's objections over Downtown deal

Swiss to reduce F-35 fighter jet order from US as costs rise

Euroclear can offset its assets seized by Russia with Russia's assets -EU

Still no deal on European fighter jets after ministerial talks, sources say

Dutch report calls for $176 billion tech spend, jobless benefit cuts

China's Changan Automobile adds Italy and Spain to its European markets

Hensoldt to supply Rheinmetall's air defence division with radars

Analysis-Oracle's stumble hits AI trade, but many remain bullish